Fisher & Paykel Healthcare Corporation Ltd (FPH.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | |
| Sales | 1,280,300 |
| Cost of Goods | 750,100 |
| Gross Profit | 530,200 |
| Operating Expenses | 901,200 |
| Operating Income | -371,000 |
| Interest Expense | 11,100 |
| Other Income | 885,400 |
| Pre-tax Income | 503,300 |
| Income Tax | 126,100 |
| Net Income Continuous | 377,200 |
| Net Income | $377,200 |
| EPS Basic Total Ops | 0.64 |
| EPS Basic Continuous Ops | 0.64 |
| EPS Diluted Total Ops | 0.64 |
| EPS Diluted Continuous Ops | 0.64 |
| EBITDA(a) | $654,300 |